Cysteine metabolism and metal toxicity.

Chronic, low level exposure to toxic metals is an increasing global problem. The symptoms associated with the slow accumulation of toxic metals are multiple and rather nondescript, and overt expression of toxic effects may not appear until later in life. The sulfhydryl-reactive metals (mercury, cadmium, lead, arsenic) are particularly insidious and can affect a vast array of biochemical and nutritional processes. The primary mechanisms by which the sulfhydryl-reactive metals elicit their toxic effects are summarized. The pro-oxidative effects of the metals are compounded by the fact that the metals also inhibit antioxidative enzymes and deplete intracellular glutathione. The metals also have the potential to disrupt the metabolism and biological activities of many proteins due to their high affinity for free sulfhydryl groups. Cysteine has a pivotal role in inducible, endogenous detoxication mechanisms in the body, and metal exposure taxes cysteine status. The protective effects of glutathione and the metallothioneins are discussed in detail. Basic research pertaining to the transport of toxic metals into the brain is summarized, and a case is made for the use of hydrolyzed whey protein to support metal detoxification and neurological function. Metal exposure also affects essential element status, which can further decrease antioxidation and detoxification processes. Early detection and treatment of metal burden is important for successful detoxification, and optimization of nutritional status is paramount to the prevention and treatment of metal toxicity.

[1]  B Lind,et al.  Mercury concentrations in the human brain and kidneys in relation to exposure from dental amalgam fillings. , 1987, Swedish dental journal.

[2]  A. Kar,et al.  Role of Testosterone in Ameliorating the Cadmium Induced Inhibition of Thyroid Function in Adult Male Mouse , 1997, Bulletin of environmental contamination and toxicology.

[3]  J. S. Woods,et al.  Reactivity of Hg(II) with superoxide: evidence for the catalytic dismutation of superoxide by Hg(II). , 1991, Journal of biochemical toxicology.

[4]  P. Kidd.  Glutathione: Systemic Protectant Against Oxidative and Free Radical Damage Dedicated to the memory of Professor Daniel Mazia, my PhD mentor and a pioneer in cell biology , 2000 .

[5]  M. Aschner,et al.  Methylmercury uptake in rat primary astrocyte cultures: the role of the neutral amino acid transport system , 1990, Brain Research.

[6]  D. Mergler,et al.  Evidence of early nervous system dysfunction in Amazonian populations exposed to low-levels of methylmercury. , 1996, Neurotoxicology.

[7]  N. Ballatori,et al.  Methylmercury transport across the blood-brain barrier by an amino acid carrier. , 1992, The American journal of physiology.

[8]  H. Sigel,et al.  Handbook on metals in clinical and analytical chemistry , 1994 .

[9]  H. L. Evans,et al.  Effect of chelation with meso-dimercaptosuccinic acid (DMSA) before and after the appearance of lead-induced neurotoxicity in the rat. , 1997, Toxicology and Applied Pharmacology.

[10]  M. Aschner.  Astrocytes as modulators of mercury-induced neurotoxicity. , 1996, Neurotoxicology.

[11]  L. Benov,et al.  Thiol antidotes effect on lipid peroxidation in mercury-poisoned rats. , 1990, Chemico-biological interactions.

[12]  Theodore Rozema,et al.  The Protocol for the Safe and Effective Administration of EDTA and Other Chelating Agents for Vascular Disease, Degenerative Disease, and Metal Toxicity , 1997 .

[13]  A O Summers,et al.  Mercury exposure from “silver” tooth fillings: emerging evidence questions a traditional dental paradigm , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  M. Aschner,et al.  Interactions of methylmercury with rat primary astrocyte cultures: inhibition of rubidium and glutamate uptake and induction of swelling , 1990, Brain Research.

[15]  Tsuguyoshi Suzuki,et al.  Toxicology of metals , 1996 .

[16]  H. Aposhian,et al.  DMSA and DMPS--water soluble antidotes for heavy metal poisoning. , 1983, Annual review of pharmacology and toxicology.

[17]  M. Aschner,et al.  Metallothionein induction in fetal rat brain and neonatal primary astrocyte cultures by in utero exposure to elemental mercury vapor (Hg0) 1 The first two authors have equally contributed to this work. 1 , 1997, Brain Research.

[18]  D. Bredesen,et al.  Cellular resistance to methylmercury. , 1996, Neurotoxicology.

[19]  L. Barregard,et al.  Endocrine function in mercury exposed chloralkali workers. , 1994, Occupational and environmental medicine.

[20]  G. Batist,et al.  Immunoenhancing property of dietary whey protein in mice: role of glutathione. , 1989, Clinical and investigative medicine. Medecine clinique et experimentale.

[21]  M. Aschner.  Astrocyte Metallothioneins (MTs) and Their Neuroprotective Role a , 1997, Annals of the New York Academy of Sciences.

[22]  C. Tohyama,et al.  High hair and urinary mercury levels of fish eaters in the nonpolluted environment of Papua New Guinea. , 1995, Archives of environmental health.

[23]  J. Salonen,et al.  Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. , 1995, Circulation.

[24]  M. Aschner,et al.  Distribution of mercury 203 in pregnant rats and their fetuses following systemic infusions with thiol-containing amino acids and glutathione during late gestation. , 1988, Teratology.

[25]  D. Echeverria,et al.  Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico. , 1995, The Journal of pharmacology and experimental therapeutics.

[26]  M. Aschner,et al.  Metallothionein induction protects swollen rat primary astrocyte cultures from methylmercury-induced inhibition of regulatory volume decrease , 1996, Brain Research.

[27]  G. Nordberg,et al.  Lead in tissues of deceased lead smelter workers. , 1995, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[28]  R. Furness,et al.  Mercury and selenium interaction: a review. , 1991, Ecotoxicology and environmental safety.

[29]  H. Komulainen,et al.  Effects of heavy metals on monoamine uptake and release in brain synaptosomes and blood platelets. , 1982, Neurobehavioral toxicology and teratology.

[30]  K. Reuhl,et al.  The molecular basis of microtubule stability in neurons. , 1994, Neurotoxicology.

[31]  P. Landrigan,et al.  Lead-induced anemia: dose-response relationships and evidence for a threshold. , 1990, American journal of public health.

[32]  R. Palmiter,et al.  Analysis of the detoxification of heavy metal ions by mouse metallothionein. , 1987, Experientia. Supplementum.

[33]  A. Miller,et al.  Dimercaptosuccinic acid (DMSA), a non-toxic, water-soluble treatment for heavy metal toxicity. , 1998, Alternative medicine review : a journal of clinical therapeutic.

[34]  J. S. Woods,et al.  Up-regulation of glutathione synthesis in rat kidney by methyl mercury. Relationship to mercury-induced oxidative stress. , 1995, Biochemical pharmacology.

[35]  G. Wetherill,et al.  Kinetic analysis of lead metabolism in healthy humans. , 1976, The Journal of clinical investigation.

[36]  A. Leviton,et al.  Occurrence of elevated protoporphyrin levels in relation to lead burden in infants. , 1986, Environmental research.

[37]  R. Palmiter,et al.  Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[38]  S. A. Winfield,et al.  Mercury vapor inhalation inhibits binding of GTP to tubulin in rat brain: similarity to a molecular lesion in Alzheimer diseased brain. , 1997, Neurotoxicology.

[39]  B. Halliwell,et al.  Free radicals in biology and medicine , 1985 .